InvestorsHub Logo
Followers 12
Posts 917
Boards Moderated 0
Alias Born 08/01/2006

Re: None

Monday, 10/31/2016 8:29:31 PM

Monday, October 31, 2016 8:29:31 PM

Post# of 8022
I think earnings will serve as a catalyst to get this back moving in the right direction.

They are generating good revenue and seem to be well run. Anticipation of approval of MACI and positive exposure on thier Heart Failure therapy ought to all contribute to a nice turnaround in the remainder of Q4.

GLTA,

Murocman
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VCEL News